Related Experiment Videos
Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines
1Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Molecular Carcinogenesis
|August 1, 1996
Summary
Mutations in the p21 gene, a key cell-cycle regulator, are uncommon in human tumor cell lines. The identified p21 variants showed similar growth-inhibitory abilities to the wild-type, suggesting mutation is not a primary inactivation mechanism.
Area of Science:
- Molecular Biology
- Cancer Genetics
Background:
- The p21/WAF1/CIP1/SDI1 gene acts as a crucial cell-cycle mediator and possesses tumor suppressor functions.
- Inactivation of tumor suppressor genes, often through mutations, can drive tumor progression.
Purpose of the Study:
- To investigate the prevalence of p21 gene mutations in human tumor cell lines.
- To determine if p21 gene mutations contribute to tumor development.
Main Methods:
- Analysis of 41 immortalized human tumor cell lines for p21 coding region mutations.
- Utilized single-strand conformational analysis and direct sequencing.
- Assessed biological activity of p21 variants using in vitro kinase assays and transfections.
Main Results:
- Two base alterations were identified in the p21 gene across the analyzed tumor cell lines.
- A known polymorphism at codon 31 and a novel substitution at codon 80 were observed.
- p21 variants exhibited comparable growth-inhibitory effects to wild-type p21 in functional assays.
Conclusions:
- Mutations in the p21 gene are not frequent in human tumor cell lines.
- p21 gene mutation is unlikely to be a major mechanism for its inactivation in cancer development.